156 Companies Bid 558 Products in China’s 7th National Medical Consumables Procurement

The breadth of participation — 156 companies and 558 products in a single round — signals that national bulk procurement has become the default pricing mechanism for medical consumables in China, not an experiment. For device makers, the relevant question is no longer whether a product category will be pulled into a national round, but when, which makes the covered list a de facto roadmap of margin risk. The price-reading session is where the actual outcome is set; how aggressively bids clear relative to prior rounds is the number worth watching.